Tobechi Brendan Nnanna

ORCID, self-asserted

ORCID 0000-0001-9702-6124

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

8 works in the graph, newest first.

Lung physiologically based pharmacokinetic modelling to predict sublingual buprenorphine kinetics following oral inhalation
2026RSC PharmaceuticsJournalOpen accessFirst authorCorresponding0 citations10.1039/d5pm00266d
Positioning Community Pharmacies in Nigeria as a Clinical Trial Partner: A Forward Perspective
2026Clinical and Translational ScienceJournalOpen accessSenior author0 citations10.1111/cts.70548
Acyclovir-induced Nephrotoxicity: Protective Potential of N-acetylcysteine
2025Journal of Exploratory Research in PharmacologyJournalOpen access2 citations10.14218/jerp.2024.00037
Preclinical Protective Activity of Lutein on Diclofenac-induced Hepatotoxicity
2025Archives of Pharmacology and TherapeuticsJournalOpen access1 citations10.33696/pharmacol.7.063
The effect of stress hormones on reproductive function in this era of prevailing climatic change
2025International Journal of Biological and Pharmaceutical Sciences ArchiveJournalOpen access0 citations10.53771/ijbpsa.2025.10.2.0084
Therapeutic Benefit of Ursodeoxycholic Acid in Tamoxifen-Induced Hepatotoxicity in Rats
2024American Journal of Internal MedicineJournalOpen access0 citations10.11648/j.ajim.20241206.12
Antituberculosis drug-induced hepatotoxicity: Preclinical benefit of glutamine
2024Eurasian Journal of ToxicologyJournalOpen access1 citations10.51262/ejtox.1554123
The protective impact of glutamine on anti-tuberculosis drug-induced nephrotoxicity in Wistar rats
2023Journal of Experimental and Clinical MedicineJournalOpen accessSenior author0 citations10.52142/omujecm.40.1.2